MARIMED INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MARIMED INC. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $0.00.
- MARIMED INC. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $0.00.
- MARIMED INC. stock issued during period, value, new issues for the quarter ending 2023-03-31 was $0.00.
- MARIMED INC. stock issued during period, value, new issues for the quarter ending 2022-06-30 was $0.00.
- MARIMED INC. stock issued during period, value, new issues for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- MARIMED INC. stock issued during period, value, new issues for fiscal 2022 was $39.00K.
- MARIMED INC. stock issued during period, value, new issues for fiscal 2021 was $0.00.
- MARIMED INC. stock issued during period, value, new issues for fiscal 2019 was $2.75M, a 91.36% decline from fiscal 2018.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $0.00 10-K · filed 2025-03-06 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $39.00K 10-K · filed 2024-03-07 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $0.00 10-K · filed 2023-03-03 |
| 2021-03-31 | $5.00K 10-Q · filed 2022-05-10 | |
| 2019-12-31 | $150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $2.75M 10-K · filed 2021-03-23 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $17.53M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $25.96M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $2.60M 10-Q · filed 2020-05-28 | $33.82M derived: sum of 4 quarters · filed 2020-05-28 |
| 2018-12-31 | $14.93M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-01 | $31.82M 10-K · filed 2020-04-01 |
| 2018-09-30 | $8.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-29 | |
| 2018-06-30 | $7.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | |
| 2018-03-31 | $600.00K 10-Q · filed 2019-05-10 | |
| 2017-12-31 | $6.58M 10-K · filed 2019-04-16 | |
| 2017-03-31 | $600.00K 10-Q · filed 2019-05-10 |